[Risk factors for atherosclerosis in obese children aged 6-12 years]

Alicja Karney1, Hanna Brągoszewska2, Leszek Soluch3

  • 1Oddział Hospitalizacji Jednego Dnia, Instytut Matki i Dziecka, Warszawa, Polska.

Insights

Childhood obesity is linked to early signs of atherosclerosis, with obese children showing higher lipid levels and increased intima-media thickness (IMT). Early detection through noninvasive methods is crucial for managing cardiovascular risks.

Area of Science:

  • Pediatric Endocrinology
  • Cardiovascular Health
  • Metabolic Disorders

Background:

  • Childhood obesity is a growing concern, contributing to metabolic and structural vascular changes.
  • These changes increase the risk of developing cardiovascular diseases and type 2 diabetes in children.
  • Early identification of risk factors for atherosclerosis in obese children is critical.

Purpose of the Study:

  • To assess risk factors for atherosclerosis in obese children.
  • To compare vascular and metabolic markers between obese children and a healthy control group.
  • To evaluate the role of family history and lifestyle factors in childhood obesity-related vascular changes.

Main Methods:

  • Study included 75 obese children (BMI >97th percentile, aged 6-12) and 36 healthy controls (BMI 75-90, aged 5-10).
  • Evaluated family history of obesity, cardiovascular disease (CVD), and dyslipidemia.
  • Measured BMI, waist circumference, lipid profiles (cholesterol, LDL, HDL, triglycerides), insulin, and intima-media thickness (IMT) via ultrasound.

Main Results:

  • Obese children had a significantly higher prevalence of positive family history for obesity (82.6%) and CVD/dyslipidemia (72%) compared to controls.
  • Obese children exhibited higher mean waist circumference (72.7 cm vs. 59.9 cm), elevated lipid levels, and nearly double the insulin levels.
  • Mean IMT was significantly higher in obese children (0.36-0.37 mm) than in controls (0.32 mm), indicating early atherosclerotic changes.

Conclusions:

  • Obesity and dyslipidemia are more prevalent in children with a familial predisposition to obesity and CVD.
  • Significantly higher IMT in obese children suggests early-onset carotid atherosclerosis, detectable by ultrasound.
  • Increased insulin levels in obese children may indicate insulin resistance, and parental knowledge gaps regarding obesity's long-term effects persist.

Related Concept Videos

Obesity01:24

Obesity

The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
1.5K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
465
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
279
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
302